Target intelligence / Profile preview

E3 ubiquitin-protein ligase RNF130 (RNF130)

Target
RNF130
Molecular classification
Enzyme, Zinc finger protein, Ring finger protein, Membrane-bound protease-associated domain-containing E3 ligase
01

Overview

E3 ubiquitin-protein ligase RNF130 is a membrane-bound ring finger protein that functions as an E3 ubiquitin ligase, mediating ubiquitination and degradation of target proteins, notably including the low-density lipoprotein receptor (LDLR), c-Myc, and regulators of apoptosis. It is structurally defined by a RING domain, a protease-associated domain, and a transmembrane segment. RNF130 regulates cellular processes such as apoptosis of hematopoietic cells, controls immune tolerance through T cell anergy, and modulates cell surface receptor abundance, impacting cholesterol homeostasis and fibrotic pathologies. It has been implicated as a tumor suppressor through epigenetic silencing in cancer and participates in metabolic reprogramming in fibrotic lung disease. RNF130 is encoded by the RNF130 gene and is also known by several aliases, including H-Goliath and Goliath homolog.

Other names
RNF130H-GoliathGOLIATHGPG1RZFPG1RPGoliath homologRING finger protein 130RING-type E3 ubiquitin transferase RNF130g1-related zinc finger protein
02

Mechanism of action

Post-translational ubiquitination. Drugs targeting RNF130 (hypothetically) would act by modulating ubiquitin-mediated degradation of its substrates, such as LDLR (to affect cholesterol levels), c-Myc (to affect cell proliferation), or proteins involved in apoptosis.

03

Biological functions

Ubiquitin-mediated protein degradationRegulation of apoptosisRegulation of immune toleranceRegulation of cell surface receptorsGene expression regulation via epigeneticsRegulation of cell proliferation and deathMitochondrial function
04

Disease associations

CancerCardiovascular diseaseFibrosisNeuro-oncologyOther diseases with apoptosis or immune dysfunction
05

Safety considerations

Potential risk of impaired immune toleranceUnwanted effects on cholesterol metabolismOff-target cell death/apoptosis, tumorigenesis
06

Interacting drugs

None directly established
07

Biomarkers

Promoter methylation of RNF130 geneRNF130 expression levelsLDLR protein abundance

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase RNF130 (RNF130).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase RNF130 (RNF130).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call